Enlarged cell morphology is a typical characteristic of senescent cells, reflecting increased cell mass (1) (2) (3) . However, the detailed components of the mass are not clearly defined, and whether the increase in mass is due to the increase of any specific cellular compartment(s), or all, is unknown. Until now, the lysosome has been the most recognized organelle increased in both senescent and aged cells (4, 5) . However, senescent lysosomes are filled with indigestible autofluorescent pigments, such as lipofuscin, and displaying non-functionality (6) . Recently, an increase in mitochondrial mass has been reported in stress-induced senescence (7) and replicative senescence (8, 9) , which was generally explained to be the result of its compensatory biogenesis to cope with the persistent functional defects of mitochondria (10, 11) . An increase in mitochondrial mass is further augmented by the inability of the lysosome to remove damaged mitochondria, thereby allowing the damaged mitochondria to continuously generate hazardous reactive oxygen species (ROS). This sequence suggests that most senescent mitochondria are also not functionally intact. The functional deterioration of mitochondrial respiration accompanied by a dramatic increase in their mass during cell senescence and aging has often been found, supporting the hypothesis (7, 12) . The close link between the accumulated non-functional organelles, mitochondria and lysosomes, yields the "mitochondrial-lysosomal axis theory of aging" (13, 14) . This theory sufficiently supports the generation of persistent oxidative stress during the progression of senescence. Analogous to this theory, the inevitable increase in non-functional organelles due to the combined actions of the uncontrolled ROS generator (mitochondria) and the non-functional eradicator (lysosome) is likely not restricted to mitochondria, but may be applied to all subcellular components. Therefore, whether all cellular organelles, especially membranous ones, are also under the compensatory enhancement of their biosynthesis and, if so, whether these features are genuinely involved in the progression of cell senescence should be evaluated. Monitoring the biogenetic activity of each organelle is not simple; however, lipid biosynthesis is a critical element for the biogenesis of all membranous organelles and may be a plausible barometer of overall membranous organelle biogenesis.
Lipid biosynthesis, called lipogenesis, includes fatty acid synthesis and the subsequent synthesis of triglycerides and membrane phosphoglycerides. Lipogenesis is activated during cell growth and proliferation to provide membranous components for subcellular organelle formation (15, 16) . Lipogenesis comprises multiple sequential steps governed by several key lipogenic enzymes, including ATP citrate lyase (ACL), acetyl-CoA carboxylase (ACC), and fatty acid synthase (FAS) (17) . ACL converts cytosolic citrate into acetyl-CoA and oxaloacetate, supplying essential metabolites for lipid biosynthesis. ACC catalyzes the irreversible carboxylation of acetyl-CoA to produce malonyl-CoA, and FAS subsequently condenses acetyl-CoA and malonyl-CoA to generate long-chain fatty acids. Interestingly, the expression of these lipogenic enzymes is controlled by the common lipogenic transcription factors, sterol regulatory elementbinding proteins (SREBPs). Three SREBP isoforms (SREBP-1a, -1c, and -2) have been identified. SREBP-1a and -1c are alternative spliced forms transcribed from two distinct promoters on the same gene whereas SREBP-2 is encoded from a different gene. SREBP-1 plays a greater role in regulating fatty acid synthesis than cholesterol synthesis, whereas SREBP-2 is relatively selective in transcriptionally activating genes involved in cholesterol biosynthesis (18, 19) . SREBPs are initially bound to the rough endoplasmic reticulum membrane but, upon activation, are cleaved to liberate the N-terminal portion containing a basic helix-loop-helix leucine zipper (bHLH-Zip) domain. The cleaved active fragment enters the nucleus, where it binds to specific sterol response elements within the promoter regions of the lipogenic genes and activates their transcription (17, 18) . Therefore, SREBP activation can be used as a good indicator of the lipogenesis status of the cell. In addition, SREBP is the best target for controlling cellular lipogenesis and exploring the relationship between lipogenesis and senescence.
In this study, we show that all subcellular organelles are generally increased with membrane lipids in both stress-induced senescence and replicative senescence. In addition, we demonstrate that lipid biosynthesis is directly involved in senescence-associated organelle biogenesis via SREBP-1 activation. These results suggest that SREBP-1-mediated lipogenesis is an important modulator of senescence and provide new insight into the metabolic background of aging and agingrelated pathogenesis. The overall organelle increase is also indicated as a novel indicator of senescence.
Experimental procedures
Cell culture, generation of cell senescence, cell growth rate -Chang cells were purchased from the American Type Culture Collection (Rockville, MD, USA) and were cultured in DMEM medium supplemented with 10% fetal bovine serum (FBS, GIBCO, Grand Island, NY) and antibiotics at 37°C in a humidified incubator with 5% CO 2 . Chang cells, immortalized normal human hepatocytes, were chosen to understand metabolic backgrounds related to stress-induced senescence due to their homogenous replicative capacity and strong metabolic properties. To generate stress-induced senescence, Chang cells were exposed to 200 µM DFO or H 2 O 2 for the indicated periods. For replicative senescence, the primary HDFs were generously provided by Dr. Lim (Ajou University, South Korea) (20 Western Blot Analysis and Antibodies -Cells were washed twice with PBS and lysed with lysis buffer [50 mM Tris-Cl, pH 7.5, 0.1 M NaCl, 1 mM EDTA, 1% (v/v) Triton X-100, 10 µg/ml each of aprotinin and leupeptin, and 1 mM PMSF]. A portion (30 µg) of the lysate was applied to western blot analysis as previously described (Yoon et al, 2006) . Antibodies against SREBP1 (cat. 557036) and SREBP2 (cat. 557037) were purchased from BD Biosciences (San Jose, CA) and antibody for α-tubulin (Ab-1) was from Oncogene (Boston, MA). Antibodies against FAS, ACC and ACL were kindly provided by Prof. Kyung-Sup Kim (Yonsei University, Seoul, Korea). The expression level of each protein was estimated by comparing the band intensities exposed on X-ray film by using Gel-Pro Analyzer 4.0 software.
Preparation and infection of recombinant adenovirus of mature form of SREBP-1 -
The recombinant mature SREBP-1 adenovirus (admSREBP1) was prepared as described previously (24) . Briefly, the cDNA encoding rat SREBP-1 (1-403 amino acids, a mature form) was cloned into pAd-YC2 shuttle vector. For homologous recombination, pAd-YC2 shuttle vector (5 μg) and a rescue vector, pJM17 (5 μg), were cotransfected into human embryonic kidney 293 cells. Pure plaques were purified and propagated in 293 cells with screening by PCR for the cloned cDNA region. Then, the recombinants were amplified in 293 cells and further isolated using CsCl 2 (Sigma). The preparations were collected and desalted, and titers were determined by the measurement of plaque counts. To over-express mature form of SREBP-1(mSREBP1) with the recombinant adenovirus (ad-mSREBP1), approximately 1x10 4 Chang cells or young HDFs (PD16) were seeded on 12 well plates and infected with admSREBP1 at the indicated titer for 12 h at 37 o C. Recombinant adenovirus of green fluorescence protein (ad-GFP, NAS0039, BioService, Korea) was used as control adenovirus.
Introduction of siRNA into cells -
and negative control siRNA (5'-UAGCGACUAAACACAUCAA-3') were produced by Samchully Pharm.Co. (Seoul, Korea). siRNA duplexes were introduced into cells using Oligofectamine (Invitrogen, Grand Island, NY, USA) according to the manufacturer's instruction.
Senescence associated β-galactosidase (SA-β-gal) assay -SA-β-gal activity was assayed at pH 6.0 as described by Dimri et al., (25) with a slight modification. Briefly, cells were washed twice with PBS (phosphate buffered saline), fixed to plates by 3.5% formaldehyde for 5 min, and then incubated overnight in freshly prepared staining solution [40 mM citrate-phosphate buffer, pH 6.0, containing 1 mg/ml of 5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside (Xgal; Sigma, St. Louis, MO, USA), 5mM potassium ferrocyanide, 5 mM potassium ferricyanide, 150 mM NaCl, and 2 mM MgCl 2 ]. The stain was visible 12 h after incubation at 37 o C. By counting the numbers of the blue and total cells using Image J software (NIH, Bethesda, MA), percentage of the SA-β-gal positive cells was obtained to estimate the degree of senescence-associated cells.
RESULTS

Overall Mass Increases in Membranous Subcellular
Organelles of Senescent Cells. First, we examined changes in mass of all cellular organelles, especially membranous ones, in stress-induced senescence triggered by deferoxamine (DFO) and H 2 O 2 as previously described (7, 26, 27) . Subcellular organelles were stained with organelle-specific fluorescent dyes and their masses were estimated by flow cytometric analysis (Fig. 1A) after confirming their specificities by visualizing with fluorescence microscopy ( Supplementary Fig.  S1 ). Unexpectedly, increased organelle mass was observed not only in lysosomes and mitochondria, but also in other organelles, such as the endoplasmic reticulum and Golgi. Whether the number of organelles was increased or whether their individual volumes enlarged without changes in number was difficult to clarify, one clear finding was that the total membranous portion of the specified organelle within a single cell was increased. In the case of the nucleus, senescent cells developed either a single giant nucleus or highly conjugated multinuclei. To estimate the membranous portion of the nucleus, we measured its single-sectioned area after staining with Hoechst 33258. Regardless of the morphological diversity, the nuclear area of most senescent cells was significantly increased compared to control cells, suggesting a marked increase in nuclear membrane (Fig. 1B) . Increased cytoplasmic membrane was also identified using an analogous approach (Fig. 1C) . Moreover, similar results of overall mass increases in membranous organelles were obtained during the replicative senescence of primary human diploid fibroblasts (HDFs) which is the best representative model of cell senescence (Fig. 1,  D and E) . These results indicate that the mass of all subcellular membranous organelles is commonly increased in senescence, contributing to the increase in cell mass. The results also suggest that membrane lipids, major components of the organelles, may increase for this phenomenon.
Increase in Membrane Lipid Content and Lipogenesis in
Senescence. Biological membranes are complex structures with up to 70% of their composition being membrane lipids. To measure membrane lipid content, total cellular lipids were extracted and separated by TLC ( Fig. 2A(a) ). Total lipids (sum of the lipids indicated as 1-5 in Fig. 2A ) increased roughly 3-fold at 2 days and 4-fold at 3 days after exposure to DFO. Potential membrane lipids (sum of the lipids indicated as 2-5 in Fig. 2A ) positioned with similar retardation as the standard membrane lipids, such as phosphatidyl ethanolamine (PE), phosphatidyl serine (PS), cardiolipin (CA), and cholesterol (CL), amounted to approximately 89% of the total lipids in control cells, and obviously increased to 95.5% in DFO-induced senescent cells while the potential storage lipid (indicated as 1 in Fig.  2A ) with similar retardation as cholesteryl palmitate (CP) decreased ( Fig. 2A(b) ). Increases in total lipid content and the membrane lipid portion were also observed in H 2 O 2 -induced senescent cells (Supplementary Fig. S2A ). Undoubtedly, old HDFs were found to have increased total lipids (2.4-fold) and an increased portion of membrane lipids (96.11% in young, 98.4% in old; Fig. 3A ). These results indicate that an increase in cellular lipids, especially membrane lipids, can also be recognized as a common characteristic of senescence, supporting the increase in organellar mass.
Next, we investigated whether the increase in membrane lipids results from the activation of lipid biosynthesis. We monitored the expression level of mature form of SREBP-1, which is known to be a master regulator of the transcription of diverse lipogenic enzymes (28) . As expected, the active mature form of SREBP-1 was clearly increased in DFO-induced senescence (Fig. 2B) . The protein levels of SREBP-1 target enzymes FAS, ACC, and ACL were also monitored. When the enzyme levels were normalized to tubulin, they reached a maximum at 24 h (Fig 2B(b) ) and then slightly decreased, which does not correlate with the pattern of total cellular lipid content. We confirmed that cytoplasmic proteins increase is much greater than nuclear proteins increase (data not shown) although nuclear mass also increase ( Figure 1B ) during cell senescence, implying that overall cytoplasmic mass is the combined result of all the other cytoplasmic organelles except nucleus. Therefore, we normalized the enzyme expression levels to lamin (nuclear protein) to represent the protein level per cell because cellular lipid contents were analyzed based on cell number. In this case, progressive and dramatic increases in the lipogenic enzymes were clearly observed ( Fig  2B(c) ). Similar results were obtained with H 2 O 2 -induced senescence (Supplementary Fig. S2C ). This increased expression of lipogenic enzymes and the active form of their master key regulator, SREBP-1c, was further observed in replicative senescence (Fig. 3, B and C) and the aging F344 rat model (Fig. 4) , even when normalized to tubulin. Taken together, these results suggest that enhanced lipogenesis via SREBP-1 activation may contribute to the increased cellular lipids of senescence and aging.
Enhanced Lipogenesis is Enough to Induce Cellular Senescence. To determine whether enhanced lipogenesis is genuinely involved in the development of cell senescence, we examined the effect of enhanced lipogenesis using the ectopic expression of active SREBP-1.
We introduced adenovirus harboring the NH 2 -terminal fragment (mature form) of rat SREBP-1 into Chang cells. As shown in Fig. 5A , overexpressed mature SREBP-1(mSREBP1) was sufficient to increase the expression of FAS and ACC without affecting endogenous SREBP-1 or SREBP-2 expression. mRNA levels of all the lipogenic enzymes (FAS, ACC and ACL) were significantly induced by mSREBP1 at the transcriptional level, implying its transcriptional activation ( Supplementary Fig. S4, A) . This finding implies that mSREBP-1 over-expression can effectively enhance cellular lipogenesis in a cell culture system. Excitedly, this enhanced lipogenesis by mSREBP-1 over-expression alone clearly induced senescence, as shown by an increase in SA-ß-gal activity, arrest of cellular growth, increased cell granularity represented by side scattering, and increased cell size represented by forward scattering (Fig. 5, B and C). The induction of senescence was further confirmed by the induction of the p21 and p16 proteins, the inhibitory cell cycle regulators (Fig.  5, A) . Similar and more remarkable results by over-expressing SREBP-1 on gain of senescence phenotypes, including SA-b-gal, granularity (SSC) and delayed cell growth in addition to induction of lipogenic enzymes were obtained in young HDFs (Fig. 6 and Supplementary Fig. S4,  B) . These data provide strong evidence that enhanced lipogenesis, at least by SREBP-1 activation, is sufficient for inducing senescence.
Blocking Lipogenesis Significantly Attenuates
Cell Senescence. Next, we investigated the effect of blocking lipogenesis on H 2 O 2 -induced senescence using siRNA-mediated knockdown of SREBP-1 or ACL expression and pharmacological FAS inhibitors. SREBP-1 knockdown effectively attenuated all senescence phenotypes induced by H 2 O 2 (Fig. 7, A and B) . Attenuation of the senescence phenotypes correlated well with intracellular ROS levels, suggesting that the enhanced lipogenesis may be tightly linked to cellular oxidative stress (Fig.  7B(d) ). The H 2 O 2 -induced senescence was also diminished by siRNA-mediated ACL knockdown or FAS-specific inhibitors cerulenin and C75 (29, 30) as shown in Fig. 7 , C and D.
Finally, we investigated whether the inhibition of lipogenesis can reverse senescent phenotypes of old HDFs, which are developed spontaneously by a series of cell passage rather than by any exogenous insult, to young-like phenotypes. For this purpose, we first determined optimal concentrations of FAS inhibitors (data not shown). Surprisingly, most senescent phenotypes of old HDFs were effectively reversed by repeatedly exposing the cells to a determined concentrations of FAS inhibitors (cerulenin and C75), though the effect on cell granularity (estimated by SSC) was minor (Fig. 8) . Higher concentrations of FAS inhibitors were toxic to cells and single treatment of the low dose was not enough to display the inhibitory effects (data not shown). These data imply that lipogenesis is importantly involved in cellular senescence and pharmacologically blocking of lipogenesis at fatty acid synthesis is an effective approach for attenuating cellular senescence.
DISCUSSION
Increases in cell mass during senescence and the aging process have often been documented (21) . Although the detailed components of the mass has not been clearly understood, increasing numbers of reports on the mass of lysosomes and mitochondria in senescence indicate that particular organelles seems to be associated with the mass of the senescent cell (4, 5, 7-9, 21). However, in the present study, we emphasize that, rather than certain organelles, all cellular organelles, particularly membranous organelles, increase during the development of cell senescence, as shown in both stress-induced and replicative senescence. These organellar mass increases correspond well with the increase in membrane lipid content and induction of lipogenic enzymes (FAS, ACC, and ACL) and SREBP-1. This finding implies that enhanced lipogenesis may contribute to the overall organelle increase in cell senescence. Therefore, in preference to investigating the changes or importance of individual organelles, we focused here on exploring the involvement of lipogenesis in the development of senescence. Indeed, enhancing lipogenesis by overexpressing mature SREBP-1 was enough to induce senescent phenotypes in both immortalized Chang cells and primary HDFs. Furthermore, blocking lipogenesis using siRNAmediated knockdown of SREBP-1 or ACL significantly attenuated H 2 O 2 -induced senescence. More interestingly, the inhibition of lipogenesis by FAS-specific inhibitors reversed the senescent phenotypes, not only of the stressinduced senescence, but also of replicative senescence. All of these results demonstrate that enhanced lipogenesis is critically involved in the senescence process, possibly contributing to the membranous organellar mass and, consequently, cell mass (Fig. 9) .
The relationship between phospholipid synthesis and senescence or aging has been discussed in only a few reports, though reports on storage fat or oxidatively damaged lipids with aging are increasing (31) (32) (33) (36) observed that de novo phospholipid synthesis declines in senescent human fibroblasts, though the formation of cholesterol was increased compared to young cells. In that same study, senescent cells developed only after the 25th passage of cell culture, whereas the young HDFs obtained from a 4-year-old boy in our study reached senescence after 75 doublings, implying that the reported cell condition was somewhat different from ours. We also observed that cells in the later stage of senescence (just before reaching cell death) contain much lower levels of lipogenic activity than well-developed senescent cells, with maximum SA-β-gal activity in both stress-induced and replicative senescence (data not shown). Interestingly, increased expression of lipogenesis-associated proteins was further found in the aging F344 rats, presenting the potential involvement of lipogenesis in the aging process. All of these reports and findings further support our hypothesis of the important contribution of enhanced lipogenesis to senescence and aging.
All mammalian cells require the biosynthesis of membrane lipids for the duplication of membranous organelles undergoing cell division. Therefore, further activation of lipogenesis is expected in cancer development, in which the strength of cell growth and proliferation is increased. Indeed, an increasing number of studies on the importance of lipogenesis in carcinogenesis have been reported, and lipid synthesis is regarded as a new target for the development of cancer therapeutics (37) (38) (39) . However, in terms of cell proliferation, cancer development is the opposite situation to senescence. Therefore, the question of why enhanced lipogenesis leads cells to senescence and not to cell proliferation is important. When we over-expressed mature SREBP-1 protein, we clearly observed p21 and p16 proteins, the negative cell cycle regulators, in addition to the increased expression of lipogenic enzymes. Although protein induction of ACC, the rate-limiting enzyme of fatty acid synthesis, by SREBP-1 was minor, overall flow of fatty acid synthesis may be enhanced by modulation of substrate (acetyl-CoA) and product (malonylCoA) levels via the increased ACC and FAS proteins. In addition, The result of the inhibitory cell cycle regulators corresponds well to the previous report that mature SREBP-1 causes cell-cycle arrest through the induction of the cdk inhibitors, such as p21, p27, and p16 (40, 41) . Therefore, enhanced lipogenesis via SREBP-1 activation alone may act as an inducer of senescence. In other words, cancer cells should acquire any additional strategy to suppress the action of the cdk inhibitors that may be induced by SREBP-1 in order to use the lipogenic power for cell proliferation.
The question then is why the senescent cells need an increased organellar mass, and whether the organelles are functional. The simple explanations previously applied to lysosomes and mitochondria are possibly applicable to these questions. Senescent cells regenerate organelles in order to compensate for the nonfunctional organelles damaged by senescenceassociated ROS as a defensive response, but the organelles that are supposed to remove the damaged organelles (components), such as lysosomes and proteasomes, have also lost their function, resulting in an accumulation of nonfunctional organelles (14, 42, 43) . The worse scenario is that even newly synthesized organelles may be non-functional due to an oxidatively stressed cellular environment, aggravating or maintaining senescence. However, in question is what happens to the newly generated organelles in the senescence induced by over-expressed mSREBP-1 protein alone, in which no additional stress exist. So far, whether the organelles have normal function, structure, and well-balanced composition, including membrane lipids and proteins, is not clear. Interestingly, knocking down SREBP-1 reduced the senescent intracellular ROS level, implying that lipogenesis is probably linked to oxidative stress. Therefore, we can hypothesize that enhancement of lipid biosynthesis alone, without supporting other components (for example, proteins) for organelles, may act as a stress by forming only lipid-enriched nonfunctional organelles. For example, in lipidenriched mitochondria, respiratory complexes may be dispersed, making their electron transfer reaction defective and increasing ROS generation. However, a detailed understanding of the functional and compositional status of individual organelles in senescence remains unexplored.
SREBP-1 is known to regulate the supply of membrane lipids in response to cell growth and is highly expressed in cells that are actively growing (44) . However, SREBP-1-expressing livers of transgenic mice exhibit impaired regeneration after partial hepatectomy (41), indirectly supporting our results that mSREBP-1 over-expression sufficiently induces senescenceassociated growth arrest. We also showed that knocking down the up-regulated SREBP-1 in the stress-induced senescent cells effectively attenuated the senescence phenotypes, indicating the potential role of SREBP-1 as a novel effective target for modulating senescence. However, we also observed that knocking down SREBP-1 below the level of control cells by using high dose siRNA also induced growth arrest (data not shown), suggesting that the wellbalanced regulation of lipogenesis is required to maintain normal cellular function and the finecontrol of SREBP-1 activation is essential to control senescence. In addition, our previous study proved that GSK3 is commonly inactivated by being phosphorylated and is also importantly involved in all the cell senescence systems (DFO-and H 2 O 2 -induced, and replicative senescence) employed in this study (27) . GSK3 is known to modulate SREBP1 activity through phosphorylation-mediated ubiquitination (45) . Therefore, it is suggested that GSK3 may play a critical role in activating SREBP-1 as an upstream modulator in senescence induced by stresses. Detailed link between GSK3 and SREBP1 in senescence is under investigation. Collectively, our results provide new insight into the metabolic background of cellular senescence and indicate SREBP-1-induced lipogenesis as a potentially effective novel target for senescence and agingrelated diseases. fig. 2A . B-C. Young (PD 15, DT 2) and old (PD 82; DT 9) HDFs were cultured and applied to Western blot analysis for SREBP-1 (B) and lipogenic enzymes (C, a). Quantitative comparison of the expression levels of the lipogenic enzymes shown in (C, b). *p < 0.05. 
